A Randomized Controlled Trial of Aspirin in Patients With Abnormal Uterine Artery Blood Flow

Abstract

Abnormal uteroplacental resistance at 18 weeks' gestation was associated with a significant increase in adverse pregnancy outcome. Low-dose aspirin did not reduce pregnancy complications in women with uteroplacental insufficiency.